Mucus matters: Ferrets demonstrate sustained fibrosis and mucociliary decrement following bleomycin-induced pulmonary fibrosis

J. Peabody (Birmingham, United States of America), S. Phillips (Birmingham, United States of America), V. Lin (Birmingham, United States of America), S. Bodduluri (Birmingham, United States of America), J. Lever (Birmingham, United States of America), R. Shei (Birmingham, United States of America), C. Hennessy (Denver, United States of America), E. Dobrinskikh (Denver, United States of America), V. Thannickal (Birmingham, United States of America), J. Engelhardt (Iowa City, United States of America), G. Tearney (Boston, United States of America), D. Schwartz (Denver, United States of America), S. Rowe (Birmingham, United States of America)

Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Session: Back to basics and translational research in idiopathic interstitial pneumonias
Session type: Thematic Poster
Number: 4807
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Peabody (Birmingham, United States of America), S. Phillips (Birmingham, United States of America), V. Lin (Birmingham, United States of America), S. Bodduluri (Birmingham, United States of America), J. Lever (Birmingham, United States of America), R. Shei (Birmingham, United States of America), C. Hennessy (Denver, United States of America), E. Dobrinskikh (Denver, United States of America), V. Thannickal (Birmingham, United States of America), J. Engelhardt (Iowa City, United States of America), G. Tearney (Boston, United States of America), D. Schwartz (Denver, United States of America), S. Rowe (Birmingham, United States of America). Mucus matters: Ferrets demonstrate sustained fibrosis and mucociliary decrement following bleomycin-induced pulmonary fibrosis. 4807

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

Modelling pulmonary fibrosis
Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations
Year: 2012

The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats
Source: Eur Respir J 2005; 26: Suppl. 49, 81s
Year: 2005

Induced sputum and respiratory function in pulmonary fybrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003

Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005



HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012

Estimation of antibiotic effect on the development of bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006

Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014


Novel biomarkers in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006

Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling
Source: International Congress 2014 – ILDs 4
Year: 2014

Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Danshenextract salt Inhibits bleomycin-induced experimental pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020


Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014


Acute exercise in cystic fibrosis patients increases neutrophilic pulmonary inflammation
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Source: Eur Respir J 2012; 40: 61-66
Year: 2012